WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Thai FM offers to resign after cabinet reshuffle
More efforts needed to boost homegrown jet
Hainan takes lead in green auto sector
Stronger support for advanced machine tools urged
Egyptian, Chinese students mark UN Chinese Language Day in Cairo
What Chinese modernization means for multinationals eyeing new opportunities in China?
Foreign automakers buoyed by recovering China mkt
Xi Story: Friends and Comrades with a Shared Mission
At least 15 killed in Israeli airstrikes on Rafah
US urged to stop slandering TikTok